Where is Akeso Biopharma headquartered?

Akeso Biopharma is located in Zhongshan, guangdong province.

Who invested in Akeso Biopharma?

Akeso Biopharma has 13 investors including Geekdom Fund And Geekdom Fund.

How much funding has Akeso Biopharma raised to date?

Akeso Biopharma has raised ____.

When was the last funding round for Akeso Biopharma?

Akeso Biopharma closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

akesobio.com

Akeso Biopharma

Akeso is a biopharmaceutical firm that develops and commercializes anti-body drugs for the treatment of cancer and autoimmune diseases.

Business Model:

Revenue: $35.4M

Employees: 1,001-5,000

Geographic Data

Address: 6 Shennong Road

City: Zhongshan

State: guangdong province

Zip: 528437

Country: CN

Financial Info

Stage:

series d

Raised Last:

$150M

Raised Total:

$220M

Social

Crunchbase

Metrics

8,390,536Website Global Rank

319Website Monthly Traffic

Twitter Followers

Description

Akeso is a biopharmaceutical firm that develops and commercializes anti-body drugs for the treatment of cancer and autoimmune diseases.

Contact Phone:

Contact Email:

IPO Details

Akeso Biopharma went public on 4/24/2020 on the Hong Kong Stock Exchange

Listed Exchange:
Hong Kong Stock Exchange

IPO Date:
4/24/2020

Ticker Symbol:
9926

IPO Price:
$2.087490089905282/share

Amount Raised:
$333M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
11/2019	Series D	12	$150M	AIHC Capital Apricot Capital BOCOM International CCB Capital CDG International Company K. Wah Group Lake Bleu Capital Loyal Valley Capital OrbiMed Shenzhen Capital Group Sino Biopharmaceutical TriWise Capital AIHC Capital Apricot Capital BOCOM International CCB Capital CDG International Company K. Wah Group Lake Bleu Capital Loyal Valley Capital OrbiMed Shenzhen Capital Group Sino Biopharmaceutical TriWise Capital
11/2015	Series A	3	$20.4M	CCB Capital Qianhai Xino Shenzhen Capital Group CCB Capital Qianhai Xino Shenzhen Capital Group
10/2018	Series C	4	$4.1M	Ally Bridge Group CCB Capital Shenzhen Capital Group TriWise Capital Ally Bridge Group CCB Capital Shenzhen Capital Group TriWise Capital
10/2018	Series C		-
8/2017	Series B	4	$45.5M	Qianhai Fund of Funds Shenzhen Capital Group ShenZhen GTJA Investment Group TriWise Capital Qianhai Fund of Funds Shenzhen Capital Group ShenZhen GTJA Investment Group TriWise Capital
4/2020	IPO		$335M
8/2017	Series B		$45M	GTJA Investment Group Shenzhen Capital Group TriWise Capital
7/2022	Private Placement		$74.1M
10/2018	Series C		-	Shenzhen Capital Group Triwise Capital Ally Bridge Group Shenzhen Capital Group Triwise Capital Ally Bridge Group

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details